Objectives Parasitic Cordyceps fungi, such as Cordyceps sinensis, is a parasitic complex of fungus and caterpillar, which has been used for medicinal purposes for centuries particularly in China, Japan and other Asian countries. This article gives a general idea of the latest developments in C. sinensis research, with regard to the active chemical components, the pharmacological effects and the research and development of products in recent years. Key findings The common names for preparations include DongChongXiaCao in Chinese, winter worm summer grass in English. It has many bioactive components, such as 3 0 -deoxyadenosine, cordycepic acid and Cordyceps polysaccharides. It is commonly used to replenish the kidney and soothe the lung, and for the treatment of fatigue. It also can be used to treat conditions such as night sweating, hyposexuality, hyperglycaemia, hyperlipidaemia, asthenia after severe illness, respiratory disease, renal dysfunction, renal failure, arrhythmias and other heart disease and liver disease. Because of its rarity and outstanding curative effects, several mycelia strains have been isolated from natural Cordyceps and manufactured by fermentation technology, and are commonly sold as health food products. In addition, some substitutes such as C. militaris and adulterants also have been used; therefore, quality control of C. sinensis and its products is very important to ensure their safety and efficacy. Summary Recent research advances in the study of Cordyceps, including Cordyceps mushrooms, chemical components, pharmacological functions and developmental products, has been reviewed and discussed. Developing trends in the field have also been appraised.
Introduction
Cordyceps sinensis (Bark) Sacc. Link (Claviceptaceae) (Ascomycetes) is an insect parasitizing fungus. The name Cordyceps comes from the Latin words cord and ceps, meaning 'club' and 'head', respectively. 'DongChongXiaCao' (DCXC), Chinese caterpillar fungus, is the Chinese name given to the complex of larvae and fungi, which is found at high altitudes on the Qinghai-Tibetan plateau. This fungus lives primarily on the head of the larva of one particular species of moth, Hepialus armoricanus, but is also occasionally found growing on other moth species. [1] It is generally called 'DCXC' in Chinese and 'Tockukaso' in Japanese, meaning 'winter-insect and summer-plant' because of the growing process: the fungus first parasitizes the larva of some species Hepiaidae, forming a parasitic complex that comprises the remains of the caterpillar and the stroma of the fungus. Because the larvae are infected by fungi in the summer and autumn seasons, and consumed by mycelia and turned into 'stiff worms' in winter, they are called 'winter worms' (DongChong). In the spring and summer season of the following year, the stroma emerges from the ground, growing from the head of the larva, and is known as 'summer grass' (XiaCao). [2, 3] C. sinensis is an invigorant in Chinese tradition and was honoured as one of the three greatest invigorants together with Panax and Pilose antlers. It has a history of hundreds of years in medicine. Its name was first seen from 'Bei Cao Cong Xin' written by Yiluo Wu in the Qing dynasty, 1757 AD and 'Ben Cao Gang Mu Shi Yi' written by Xueming Zhao in 1765 AD. The French mycology scientist proved that C. sinensis is a type of Ascomycetes which parasitizes insect larvae, grows and gradually changes into a fruit body. [4] It is the combination of fungus and larva. However, it is more difficult for authors in the scientific literature to define a formal name. The preparation has been considered to have healing properties for the body and mind; DCXC is still revered by some people. The preparation does indeed contain certain bioactive ingredients (such as 3 0 -deoxyadenosine, cordycepic acid, cordycepic polysaccharides) that might be beneficial for the prevention and treatment of a variety of ailments, such as respiratory disease, renal dysfunction, hyposexuality and cancers. Many of the related biomedical investigations have been conducted predominantly in China, Japan, Korea and the US, and are extensive.
Modern experimental methods in biochemistry have proved that C. sinensis consists of active constituents such as mannitol, nucleosides, ergosterol, aminophenol and trace elements. [5] It has a broad medical effect, and its function of immunity regulation plays an important role in antitumour effects, organ transplantation and the prevention of kidney, liver and heart disease. [6, 7] The Chinese Pharmacopoeia (2005) records that the main functions of C. sinensis are replenishing the kidney, soothing the lung, staunching bleeding and dispersing phlegm. It can also be used to treat continuous cough caused by fatigue, asthma, haemoptysis, impotence, spermatorrhoea and aches in abdomen and knee. [8] Previous studies mostly focused on aspects such as the resources of C. sinensis, its active chemical components and its pharmacological effects. Recently people have paid more attention to protecting the resource and seeking substitutes, and they hope to sustainably utilize this precious medical epiphyte. This article gives a general overview of the latest developments in C. sinensis research, with regard to the active chemical components, the pharmacological effects and the research and development of products in recent years.
Related Species and Artificial Cultivation
C. sinensis is a complex of larva and parasitic fungus. Many species in this genus are valuable medicinal fungi with broad development potential. The parasitic complex of the fungus and caterpillar, well known as 'DCXC', is only found in the prairie soil at an elevation of 3500-5000 m. It is mostly distributed in Tibet, Qinghai, Sichuan, Yunnan and Gansu province in China. The fungus and caterpillar complex is limited to C. sinensis and Hepialus armoticamus Oberthur, while complexes consisting of other species of fungi and insects are called 'ChongCao', not 'DCXC'. [9] Cordyceps encompasses several Cordyceps species, which are widely used for medicinal purpose (e.g., C. liangshanensis Zhang, Liu et Hu, C. taishanensis Liu et Cao, C. shanxiensis Liu, Rong et Jin, C. gansuensis Zhang, Wang et Yan, C. grasspara Zang, Yang et Li, C. kangdingensis Zang et kingjo, C. guizhouensis Liu, Liang et Liu, and so on). In addition to C. militaris, C. nutans Pat. and C. tricentri Yasuda, some species such as C. gunnii (Berk.) Berk. and C. Roberts (Hook.) Gray, which are usually distributed on the Australian mainland, may be found in China (Zhang, 2003) . [9] More than 400 Cordyceps species have been described worldwide and approximately 90 Cordyceps species are distributed in China; [10] C. militaris can be used to replace C. sinensis. A number of macroscopically similar species have been described, which are either considered as being homogeneous with C. militaris, or are simply unnoticed among large collections from a variety of hosts and life-cycle stages. [11] [12] [13] Much research into the chemical composition, pharmacological efficiency and clinical application of C. sinensis and its substitutes, such as Hirsutella spp., Paecilomyces spp. and C. militaris, is underway. [4] However, in therapeutic practice and literature citations, the term Cordyceps always refers to the species C. sinensis.
In the early 1980s, many scientific institutes began to study the cultivation of C. sinensis. Previous work, over the course of a decade, was mainly focused on the anamorphic fungi related to C. sinensis. Shen Nanying made a success of culturing fruit bodies in 1985. The Sichuan TCM Institute also achieved the artificial cultivation of C. sinensis, although commercial production has not been carried out because of the high cost and low stability. [14] Up to now, in fact, the artificial cultivation of this valuable fungus has not been successfully achieved; only a product made using a C. sinensis anamorph has been made by fermentation methods. [15] Subsequently, production of C. sinensis, mostly added to traditional Chinese medicine (TCM) patent prescriptions, has developed rapidly, particularly in China. Nevertheless, only C. militaris, producing 3 0 -deoxyadenosine, has similar pharmacological activity to C. sinensis, whose biological characteristics were studied early in the 1950s. [16] Compared with C. sinensis, the artificial cultivation of C. militaris was easier and successfully achieved in the early 1980s. [17] At that time the multi-product batch manufacture had been achieved; now the mycelia may grow in rice (or kernel) medium and produce fruiting bodies. The process of producing C. militaris fruiting bodies is the same as for other cultivated edible mushrooms and can be divided into two major stages. The first involves the preparation of the fruiting culture, stock culture, mother spawn and planting spawn, while the second entails the preparation of growth substrates for mushroom cultivation. [18, 19] Currently, the method most widely adopted for commercial production is the cooked rice in bottle procedure (for cultivation details, see Zhang [19] , Ren et al., [20] Wen et al. [21] ).
constituents, cordycepin and cordycepic acid, have been identified and proposed as important active constituents. [1, 22] It is now believed that cordycepic acid is, in fact, D-mannitol, and that cordycepin is 3 0 -deoxyadenosine (3
0
-dA), a purine alkaloid, a derivative of the nucleoside adenosine, differing from the latter by the absence of oxygen in the 3 0 position of its ribose part (Figure 1 ). Early in 1950 cordycepin was first isolated from C. militaris and its structural formula was confirmed as 3 0 -deoxyadenosine. [23, 24] Subsequently, by means of nuclear magnetic resonance (NMR) and infrared (IR) spectroscopy, cordycepin as a bioactive component was extracted from the fruiting bodies and cultured mycelium of C. sinensis and the configuration elucidated. The molecular weight of cordycepin, C 10 H 13 N 5 O 3 , is 251. Its melting point is 230-231 C, and maximum absorption is at 259 nm. It can be dissolved in saline, warm alcohol or methanol, but not in benzene, ether or chloroform, so many researchers in laboratories used sterilized saline and phosphate-buffered saline (PBS) as solvent. [25] In general, the content of 3 0 -dA in the mycelia fermentation preparations (40.8 mg/g) [26] is more than that in the fruiting bodies of C. sinensis (< 5.4 mg/g). [27, 28] Cordycepic acid, an isomer of quinic acid, is one of the main active medicinal components. The chemical constituents of C. sinensis were first studied in 1957, when a crystalline substance was isolated and the structure was imprecisely concluded to be 1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid. [29] Subsequently, the structure of the crystalline substance named 'cordycepic acid' was identified by Sprecher and Sprinson [30] as D-mannitol. Mannitol is a major bio-product with important biological activity, and exists in the wild in the roots, stems and leaves of plants, while more is found in edible fungus, carrot and lichens. In general, the content of cordycepic acid in DCXC is 7-29%, differing in the various growing stages of the fruiting bodies. [31] It is used not only in injections as raw material, but also as a supplement in other medicines. [32] Chemically, mannitol is an alcohol and a sugar, or a polyol; it is similar to xylitol and sorbitol. However, mannitol has a tendency to lose hydrogen ions in aqueous solution, which causes the solution to become acidic. For this reason, it is not uncommon to add a substance to adjust its pH, such as sodium bicarbonate. The chemical formula of mannitol is C 6 H 14 O 6 , its molecular weight is 182, its melting point is 166 , its relative density is 1.489 (20 C) and its boiling point is 290-295 C (467 kPa). Mannitol, as a functional polyol with notable properties, has been widely used in the medicine and food industries. The content of mannitol varies with the original habitat. In general, there is about 29-85 mg/g in Cordyceps fruiting bodies; the mannitol content in the mycelia of Cordyceps is higher than in fruiting bodies. [33] Polysaccharides Cordyceps contains a large amount of polysaccharides, which can be in the range of 3-8% of the total weight, [34, 35] and usually comes from the fruiting bodies, the mycelium of solid fermentation submerged cultures and the broth. Cordyceps polysaccharide (CP), one of the main bioactive components, represents a class of structurally diverse biological macromolecules with wide-ranging physiochemical properties. The anti-tumour and immunomodulating activity of the medicinal mushrooms has already been brought to scientific and commercial attention. [36, 37] Since 1977, much of scientific investigation in Japan and China has been performed to discover possible functional polysaccharides; many CPs and their components have been isolated and characterized from wild and cultivated Cordyceps species (Table 1) .
CP is a multi-branched galactomannan. Based on activityguided fractionation, a water-soluble protein-containing galactomannan was isolated from the sodium carbonate extract of Cordyceps, and its molecular weight was estimated by gel filtration to be 23 kDa. The isolated compound is composed of D-mannose and D-galactose in a molar ratio of 3 : 5, and contains a small proportion of protein. It is a highly branched structure and composed of (1!6)-and (1!2)-linked a-D-mannopyranosyl residues in the main chain. [56] Cai et al. [60] developed a method to study the topography of CP by using an atomic force microscope (AFM). The result showed that CP has a multi-branched structure and a variety of different linkages between adjacent monosaccharides, which make up the small rings and helical structures. However, a neutral mannoglucan with a molar mass of approximately 7700 g/mol was obtained recently from CP, which consisted of Man and Glc units in the molar ratio of 1 : 9. Analysis showed that it had an alpha-D-glucan backbone with (1!4)-and (1!3) linkages, and Cordyceps fungi Xuanwei Zhou et al. Fruit mycelium of C. sinensis [39] 5 P CI Fermentation broth of C. dipterigena [41] 13 CG-1
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the side chains of alpha-D-(1!6)-mannopyranose (Manp) were attached to the backbone via the O-6 of alpha-(1!3)-glucopyranosyl (Glcp) residues. [61] The study showed that the pharmacological activity of the polysaccharide was correlated with its characteristics such as molecular weight. It has been reported that polyglucans with higher molecular weight (10-1000 kDa) tend to have greater water solubility and therefore have a more effective antitumour activity. The anticancer effects of fungal polysaccharides arise from the enhancement of the body's immune system rather than direct cytocidal effects. [62] The physicochemical properties of an aqueous solution of crude CP have been analysed, and the result showed some good properties, such as thickening and thixotropic properties, salt and heat resistance and stability over a wide pH range. The dynamic viscosity of CP varies little over the pH range of 4-14. There was a positive relationship between CP oral dosage and its therapeutic effects (the lowest effective dosage of CP is 180 mg per day). [40] In addition it is colourless and odourless and has good solubility and stability in water. [63] Other Bioactive Components Nucleotides Nucleotides (including adenosine, uridine and guanosine) are effective components in Cordyceps mushrooms. Investigations show that guanosine has the highest content of all in natural and artificial Cordyceps. [64] The content of nucleotides in artificial Cordyceps is obviously higher than in natural Cordyceps. This may be related to the rapid metabolism of artificial cultures. A remarkable variation in the adenosine content is found in artificial Cordyceps, with the highest concentration being over six times that of the lowest. The content of adenosine in freshly acquired natural Cordyceps is too low to quantity, but the content of the nucleotide in a preparation stored for a long time is higher. This shows that nucleotides in natural Cordyceps derive from degradation of the nucleoside during the storage process. Subsequent research found that dampness and warmth can significantly increase the nucleotide content in Cordyceps. At a temperature of 40 C and relative humidity of 75%, Cordyceps were stored for 10 days, when the content of nucleotides increased 1-10 fold, while in artificial Cordyceps adenosine, uridine and guanosine showed no obvious change in content. This suggests that the nucleotides in natural and artificial Cordyceps are to some extent different. [5] Ergosterol Ergosterol is a sterol unique to fungi and is an important precursor of vitamin D 2 , which has important medicinal value. The content of free ergosterol from natural and artificial Cordyceps has been compared. The result showed that the content of free ergosterol in different natural Cordyceps varies significantly, but is evidently higher than than in the mycelia of Cordyceps. The content of ergosterol in the artificial fruit body of C. militaris is very high, only lower than that of natural Cordyceps in Tibet, and higher than that in Qinghai and Sichuan. Li et al. [65] reported that the content of ergosterol in the mycelia of Cordyceps was 1.44 mg/g, much lower than that in the fruit bodies of Cordyceps (10.68 mg/g).
Crude protein and amino acids
Previous papers have reported that the content of crude protein was in the range 29.1-33%. [27, 33, 66] The protein was composed of 18 amino acids, including aspartic acid, threonine, serine, glutamate, proline, glycine, valine, methionine, isoleucine, leucine, tyrosine, phenylalanine, lysine, histidine, cystine, cysteine and tryptophan. The content of amino acids after hydrolysis is mostly reported as 20-25%, the lowest being 5.53%, the highest being 39.22%. The highest contents are glutamate, arginine and aspartic acid, and the major pharmacological components are arginine, glutamate, tryptophan and tyrosine. [67] The content of amino acids in the commercial preparation of Cordyceps is significantly higher than in the mycelia of C. sinensis, which is similar to the content in the fruit body of C. sinensis. The content of amino acids in C. sinensis and related products are shown as in Table 2 .
Fatty acids and metal elements
Fatty acids are composed of carbon, hydrogen and oxygen and are the major component of lipids, phospholipids and glycolipids; they can be classified as saturated or unsaturated fatty acids. In Cordyceps, the unsaturated fatty acid content reaches 57.84%, including C l6:1 , C l7:1 , C l8:l and C l8:2 . The linoleic acid content is the highest at 38.44%, followed by the oleic acid, which is 17.94%. The saturated fatty acid content is 42.16%, including C l4 , C l5 , C l6 , C l7 , C l8 , C 20 and C 22 . The palmitic acid and the octadeca acid contents are the highest, and are 21.86% and 15.78%, respectively. Unsaturated fatty acid is an effective physiologically active component, which has the unique function of decreasing blood lipids and protecting against cardiovascular disease. The content of unsaturated fatty acid is higher than that of saturated fatty acid in commercial preparations of Cordyceps, and the linoleic acid and oleic acid contents are significantly higher than others. The amino acid level in the C. sinensis fermentation preparations were more than those in the C. sinensis fruit body.
Investigations show that Cordyceps contains many metal elements, and the content significantly depends on different species and metal elements (Table 3) . [26, 68, 69] Many metal elements, Zn, Mg, Mn and so on, are of great significance to the development and maintenance of function of the gonads. Zn is effective in the kidney at preventing cadmium from damaging the nephrons. [70] High contents of Zn, Mg, Mn play an important role in warming and tonifying the kidney yang effectively, aiding kidney recovery and improving the essence of life. [71] 
Pharmacological Function
Fungi are an important source of material in TCM. Medicinal mushrooms have an established history of use in traditional oriental therapies. Extracts from about 200 species of fungi have been shown to stimulate immunoreactivity and inhibit the growth of different kinds of tumours. [72] [73] [74] [75] According to the theory of TCM, the main effects of Cordyceps are enriching the lung yin and yang, which includes treating chronic lower back pain, sensitivity to cold, over abundance of mucus and tears, chronic cough and wheezing, blood in phlegm from consumption due to kidney yang (shenyangxu), etc. Based on Western medicine, Cordyceps has an antibacterial function, and reduces asthma, lowers blood pressure and strengthens the heart beat. In the public domain, people often add it into hen or duck soup to strengthen the body and 'renew' sick people. [3, 76] Although there are 300 species of Cordyceps, the research into its pharmacological effect has focused only on two species, C. sinensis and C. militaris.
Antitumour effects
Tumour diseases are one of the main causes of death in the world. Antitumour activity is the most significant therapeutic interest associated with these mushrooms. The ability to inhibit the growth of different tumours was detected in many genera of Cordyceps species. Cordyceps species and their extracts have been recognized as a traditional remedy, used in TCM for the prevention and treatment of cancer and several other diseases. [77] The bioactive components in Cordyceps that have antitumour activity are mainly the polysaccharides, sterols and adenosine. The antitumour action of CP has been proved extensively, [40, 59, 78, 79] and that of sterols and adenosine is a hot research topic in Cordyceps. [80, 81] New antitumour compounds have been continually isolated, and the effects of Cordyceps extract on tumour growth have been evaluated. [82, 83] For instance, Zhang et al. [84] compared the antitumour effects and chemical components of the extracts of cultivated C. sinensis with natural C. sinensis. The Cordyceps was extracted with petroleum ether (PE), ethyl acetate (EtOAc), ethanol (EtOH) or water. The cytotoxicity of all the extracts was observed with MTT assay on a breast cancer cell line (MCF-7), a mouse melanoma cell line (B16), a human premyelocytic leukaemia cell line (HL-60) and a human hepatocellular carcinoma cell line (Hep G2). The chemical constituents in the extracts were analysed by HPLC. The results showed that all of the extracts from the Cordyceps mushroom had much stronger cytotoxicity on the B16 cell line and the EtOAc extract had the most potent activity; the chemical components of all the extracts were analysed and ergosterol and adenosine were found to be potential compounds. [84] We still do not know the mechanism by which Cordyceps inhibits the growth of various cancer cells; inhibition might occur by one of several means, summarized as follows: (1) enhancing immunological function and non-specific immunity; [85] (2) selectively inhibiting RNA synthesis, thereby affecting the protein synthesis; [86] (3) restricting the sprouting of blood vessels; [87] (4) inducing tumour cell apoptosis; [88] (5) regulation of signal pathways; [89] (6) antioxidation and anti-free radical activity; [90] (7) anti-mutation effect; (8) interfering with the replication of tumour-inducing viruses; (9) inducing nucleic acid methylation. [91] Immunomodulating effects
The possibility that extracts and isolated components from mushrooms stimulate or suppress specific components of the immune system has been studied in recent years. Immunomodulators can be effective agents for treating or preventing diseases and illnesses that stem from certain immunodeficiencies and other depressed states of immunity. [92] There is an extensive body of research focused on the immuno-enhancing and immunosuppressive properties of various Cordyceps species. [93, 94] As previously stated, several major substances with immunomodulatory activity have been isolated from Cordyceps. Metal levels in Cordyceps sinensis mycelium preparation were more than those in fruit body; n.d., not detected; n.t., not tested.
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The major immunomodulating effects of the active substances derived from these mushrooms include mitogenicity and activation of immune cells, such as the lymph proliferative response, natural killer (NK) cell activity and phytohaemagglutinin (PHA)-stimulated interleukin-2 (IL-2) and tumour necrosis factor-a (TNF-a) production on human mononuclear cells (HMNC), [6] resulting in the production of cytokines. The therapeutic effects of the mushrooms, such as suppression of autoimmune diseases and allergy, have been associated in many cases with their immunomodulating effects. [95] [96] [97] While it is known that Cordyceps extracts have immunomodulatory activity, the standard approach has been to isolate, characterize and administer the pure active constituents. However, different components in a Cordyceps species extract may have synergistic activity. There are several reports of mushrooms containing more than one polysaccharide with immunomodulatory activity. For example, Yu et al. [98] used components I, II, III and IV of polysaccharide groups and a negative control group. Administration of C. sinensis polysaccharides to NIH mice lasted for five days at a dose of 35 mg/kg by intraperitoneal and subcutaneous injection. They investigated the pharmacodynamics of immune activity of different components, measured the weight of thymus and spleen of mice injected intraperitoneally, and then calculated the viscera index for those injected subcutaneously. The results indicated that different components of C. sinensis polysaccharides could enhance the immune response, spleen index, thymus index and the phagocytic function of monocyte-macrophages. [98] The response to different polysaccharides is likely to be mediated by different cell surface receptors, which may be present only on specific subsets of cells and may trigger distinct downstream responses. A combination of such responses involving different cell subsets could conceivably provide greater tumour inhibition than that which could be induced by a single polysaccharide. [78] On the other hand, latest reports show that Cordyceps has an anti-rejection effect in the experimental research of organ transplantation. For example, Guan and Yu [99] studied the prevention of rejection of transplanted kidney by artificial cultured Cordyceps in rats; the results showed that Cordyceps powder can markedly prolong rat renal allograft survival.
Protective effects on human organs Protection of liver
Liver disease is one of the major diseases that is seriously harmful to human health and affects quality of life. The incidence of primary liver cancer is continuously rising in the world, and about 50 000 people die of this disease every year, of which about 40% are in China, which may be related to hepatitis virus infection. Thus effort has concentrated on preventing liver disease using TCM, and Cordyceps is one of the various materials of TCM.
Animal tests and clinical research data show that Cordyceps has a protective effect in liver patients, including those with viral hepatitis A, chronic hepatitis B, chronic hepatitis C, hepatic fibrosis, etc. It enhances organic cell immunological function, reverts HBeAg-positive to HBeAgnegative, improves liver function, inhibits hepatic fibrosis, and so on. [100] In recent years, significant progress has been made in the prevention of liver disease. For instance, to find an effective drug to cure patients with chronic hepatitis B, Gong et al. [101] have treated 25 patients with C. sinensis. T lymphocyte subsets (CD4, CD2), hyaluronic acid (HC) and precollagen type III (PC III), were observed before and after treatment. After 3 months of treatment, CD4 and CD4/ CD2 ratio increased significantly (P < 0.05), while HA and PC III decreased significantly (P < 0.05) compared with the control. These results suggested that beneficial effects might be obtained by using C. sinensis to adjust the T lymphocyte subset levels and to treat hepatic fibrosis in patient with chronic hepatitis B. [101] Bioactive components of cordyceps for liver protection are mostly CPs. The CPs can improve the immunological functions of organic cells, removing harmful components and thus reducing the injury to liver cells. However the content and efficacy of CPs vary with the species. [102, 103] The effects of CPs in protecting the liver were presented as follows: [104] (1) protective effect on immune liver injury; (2) effect on patients with chronic hepatitis B; (3) effect on patients with hepatocirrhosis after hepatitis; [105] (4) protective effect on liver fibrosis. [101] The key to treating liver disease is to inhibit and clear the virus from the liver of patients, regulate the immunological function of the organism, and reverse the developing process of liver fibrosis, etc. C. sinensis and its related products obviously act to hasten macrophage phagocytosis, and enhance the immune function of organisms and possess a strong capacity to clear the virus. [106] Protection of kidney Nephrosis is a kidney disease, always considered to be serious, which is harmful to the health of the urinary system. It can recur easily and acutely, while it is difficult to cure. The modern method of treatment still lacks a satisfactory curative effect. The medical treatment for the disease mainly uses glucocorticoids and an immunodepressant. The Chinese native medicinal treatment for nephrosis has a rapid effect, and the side effects are also very small, so it is given prominence. [107] In DCXC, there are about 19 amino acids, alcoholic components, nucleotides, trace elements and vitamins as previously stated. The effects in protecting the kidney are mainly presented as three aspects: (1) a therapeutic effect on toxic kidney injury; (2) protecting against chronic renal function failure; (3) reversing the effect of glomerulonephritis in an animal model. [7] These have been proved by a series of experiments.
Protection of heart and antihypertensive effects C. sinensis extracts were tested on myocardial ischaemia/ reperfusion injury in rat isolated hearts. Xu et al. [108] reported that the alcoholic extracts had a protective effect on myocardial injury induced by adriamycin in rats. The mechanism was suggested to be that mannitol, amino acids and polysaccharides in the extracts played an important role; all the substances had the effect of nourishing the myocardium and enhancing its anti-injury capacity. [108] With the same experimental methods, Gu et al. [109] reported that Lungfit (C. sinensis compounds) could be beneficial for myocardial ischaemia/reperfusion injury as well. However, both alcohol and water extracts had obviously protective effects on the rat isolated heart. On the other hand, C. sinensis has an inhibitory effect on arrhythmias induced by aconitine, barium chloride and adrenaline, and can increase nutritional myocardial blood flow, thereby improving myocardial ischaemia. [110] Some other papers reported similar findings, but isolates came from different extraction methods. [111] Considering antihypertensive effects, Wu et al. [112, 113] observed the effect of C. sinensis on blood pressure in renal hypertensive rats. The results showed that the renal hypertension could be prevented significantly by treatment with C. sinensis since the cardiac hypertrophy and vascular remodelling were reversed. Therefore, they came to the conclusion that C. sinensis has a curative role in renal hypertension. [112, 113] In short, C. sinensis has many effects on the cardiovascular system, such as having a negative frequency, reducing myocardial oxygen consumption, improving myocardial ischaemia, anti-platelet aggregation and anti-arrhythmic effects, etc. On the haematopoietic system, C. sinensis has a protective effect on mice platelet reduction and platelet ultrastructural damage.
Protection of other organs
C. sinensis also has obvious effects on other organ systems. [114] [115] [116] For example, on the central nervous system, C. sinensis has sedative, anticonvulsant and cooling effects. On the respiratory system, C. sinensis has a significant relaxant role in the bronchi, markedly increases adrenaline secretion from the adrenal glands and also has a role in tracheal contraction caused by histamine; it also has an antitussive, expectorant and anti-asthmatic action and prevents pulmonary emphysema. On the endocrine system, C. sinensis has effects as a male hormone; CP can increase plasma corticosterone levels, etc.
Developmental Products
In recent years, functional foods, also known as nutraceuticals, medical foods or nutritional foods, are driving food markets around the world and are expected to be one of the emerging trends for the food industry in the new millennium. Cordyceps are important raw sources. As the prices of Cordyceps are rising fast, many people harvest them. Meanwhile animal husbandry is developing rapidly, which destroys the ecological equilibrium, reducing the wild Cordyceps resources. To increase the yields of Cordyceps and meet medicinal demand, researchers have tried to obtain the purified mycelium of Cordyceps from the artificial fermentation of the stroma of Cordyceps since the 1970s. Due to their similarity in biological activity and chemical composition, there will be a trend towards replacing natural Cordyceps resources. So far many fungi have been studied further, including Cephalosporium sinensis, Paecilomyces hepiali, P. sinensis, Scydalium spp. and C. militaris, and many different improved productions have appeared on the market. [13] At present, the development of Cordyceps and its substitutes is mainly focused on the following three areas.
Dietetic Chinese drugs
Dietetic Chinese drugs are also known as 'edible Chinese drugs', 'dietetic material medicine' or 'medicinal food', although the word 'drug' could be misinterpreted in the West. The basic theories of the Chinese medicated diet (CMD) arose from the main theories of herbal medicine in TCM. [117] Accordingly, the homologous culture of medicine and food are an important part of TCM theory; there is a saying: 'food is your medicine, and medicine is your food'. Much Chinese herbal medicine not only involves the treatment of disease, but also includes very good food, such as daily vegetables and fruits, which have the dual role of being food and drug at the same time. C. militaris, as healthy green food, could be used in stir-fries or be added to stewed chicken or duck, cooking soup, hot pot and tea. Especially, cooking soup with Cordyceps is very popular. Now the Guangdong Academy of Agricultural Sciences Institute of Sericulture and Insects has developed a series of tea herbs. What's more, the Chengdu JinCao Company has prepared food with C. militaris which is aimed for mass consumption, such as Cordyceps-Saussurea, Cordyceps-Aloe and Cordyceps-Dictyophora soup. [118] Health food Health food, also called 'functional food', is used widely and designed as foods or food components that help to modulate the human body and cure or prevent diseases. Many other terms, such as 'medical foods', 'nutraceuticals', 'nutritional foods' and 'designed foods', as well as their definitions, have also emerged. Health foods need to be approved by the SFDA (State Food and Drug Administration) in China and before marketing. Therefore, developing health food is another important way to develop Cordyceps products directed to different people and different physiological states with different demands of nutrition and health. There has been some C. militaris health food on the market, such as oral liquid Cordyceps tonic, tonic Cordyceps wine for kidney reinforcing, [119] Cordyceps health beer, Cordyceps capsules (such as AiMei soft capsule, using the tradename 'Xinkeqi', which has the unique function of immunomodulation and delaying senility, produced by Jilin Xinkeqi Health Food Co., Ltd), and so on. [120] These have been used mainly by the following groups: young people, the elderly, pregnant women, people with nutritional imbalance and so on. Focused design like this not only influences physiological regulation, but also regulates the nutrition and senses.
It is worth noting that, in recent years, as increasing attention is given to the function of C. militaris, foreign manufacturers have shown an interest, and export volumes are increasing. Presently Japan, Korea, Malaysia and other countries are increasing their research and development of Cordyceps functional food. [10] Developing the 'drugs'
The most bioactive components extracted from Cordyceps, such as cordycepin, cordycepic acid and CP, which have anti-aging and sleep regulating effects, have been authorized as new medicinal resources by the SFDA of China. Therefore, using Cordyceps (including its extracts) and adding other TCM materials or other nutrient resources, we can develop many products through modern technology. These products have many functions that are mainly focused on the following aspects: enhancing physique, anti-aging, protecting the heart, improving sleep, increasing appetite, increasing immunity, etc. For example, 'C. militaris mycelia powder and the capsule of C. militaris mycelia powder' had been authorized as a Chinese national drug in April 2003; Jilin Northeast Tiger Pharmaceutical Co., Ltd reported to the State Ministry of Health to declare classes of new drugs, which have been approved and called Xinkeqi Capsules. Meanwhile, 'C. sinensis polysaccharide liposomal oral liquid' (Guangzhou Xingqun Pharmaceutical Co., Ltd), [121] and 'Bailing Capsules' (Hangzhou Eastchina Pharmaceutical Co., Ltd), [122] have also been approved for entry into the market. So far, there are approximately twenty types of TCM preparation related to Cordyceps, many of which are polysaccharide products. [123] 
Concluding Remarks
Cordyceps, one of the well-known TCMs, consists of the dried fungus C. sinensis growing on caterpillar larvae. These larvae include about 20 species of five genera, Hepialus, Hepialiscas, Napialus, Forkalus and Bipectilus, which are classified as Hepialidae. Among them, Hepialus armoricanus, H. obilfurcus, H. baimaensis and H. renzhiensis are predominant hosts of C. sinensis. [124] The parasitic complex of the fungus and the caterpillar is found in the soil of the prairie at an elevation of 3500-5000 m. [122] It is commonly used in China to replenish the kidney and soothe the lung, for the treatment of fatigue, night sweating, hyposexuality, hyperglycaemia, hyperlipidaemia, asthenia after severe illness, respiratory disease, renal dysfunction and renal failure, arrhythmias and other heart disease and liver disease. The natural Cordyceps (wild C. sinensis) is rare and expensive in the local market; researchers in China have extensively observed its life cycle with the aim of developing techniques for isolating fermentable strains of C. sinensis. Several mycelial strains have been isolated from natural Cordyceps and manufactured in large quantity by fermentation technology. At present, cultured Cordyceps mycelia are commonly sold as health-food products in South East Asia. [125] According to incomplete statistics, at present there are about 100 scientific research institutes working on the research and development of medicinal fungi. More than 200 factories are engaged in producing fungus preparations. In China, there are more than 30 kinds of medicinal fungus that are used for obtaining their active component or mycelium and fermentation production by solid-state fermenting or deep-seated fermenting. This provides abundant materials for manufacturing medicine. By now, there are 20-30 types medicament products and approximately 100 types of health-care products. [126] In order to develop, utilize and protect this rare medicinal resource, the Chinese government has bestowed it special support and sponsored much research by the national research foundations over recent years. For instance, during the seventh five-year plan (1986) (1987) (1988) (1989) (1990) , many research institutes were engaged in the research and development of Cordyceps in Shanghai, Shanxi, Jiangxi and Qinghai provinces, after the national science committee put research into C. sinensis in the Spark Plan Project. Subsequently, the research and development of Cordyceps has been listed as a key project to be pursued in the science and technology area for three continuous five-year plans (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) , from the seventh five-year plan (1986) (1987) (1988) (1989) (1990) to the ninth five-year plan (1996) (1997) (1998) (1999) (2000) . For example, 'wild cultivation, research and development of C. sinensis in the Naqu District of Tibet', China Key Science Program in the national ninth five-year plan, strongly supports the cultivation of C. sinensis by simulating its naturally growing environment, and exploiting its production in the north Tibet altiplano. [4] 'The R&D of cordycepin polysaccharide' (No. 96-C03-01-03), which was listed in the key project of the ninth five-year plan, is not only a breakthrough in the theoretical research of Cordyceps, but it also has an active significance for the development of Cordyceps products. [127] During recent decades, as the findings of new uses for Cordyceps and development of Cordyceps preparations continues, some correlative products have rapidly appeared one after another, such as Cordyceps capsule, Cordyceps oral liquid, Cordyceps drink and so on. The development of the curative and health-care products from Cordyceps is more and more favourable among people in China. Meanwhile, we are facing an arduous task. C. sinensis, with its long history and remarkable efficacy, cannot continue to serve for the health of human beings, so we must be clearly aware of this and make efforts to discover a substitute for C. sinensis. It is delightful that the eleventh five-year-plan annual emphasis item of 2007 in the medicine technology field of 863 Program (Hi-tech research and development program of China) also strongly supports the research on C. militaris as a substitute for C. sinensis. It is credible that a substitute having the same efficacy as C. sinensis will appear in the near future and well serve the human being's health project.
